Biomarin Pharmaceutical Inc
(NAS:BMRN)
$
66.16
0.03 (0.05%)
Market Cap: 12.61 Bil
Enterprise Value: 12.26 Bil
PE Ratio: 39.62
PB Ratio: 2.33
GF Score: 67/100 Biomarin Pharmaceutical Inc at Robert W Baird Global Healthcare Conference Transcript
Sep 12, 2023 / 05:25PM GMT
Release Date Price:
$92.06
(+1.32%)
Joel Lawrence Beatty
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
Good afternoon, everyone, and thank you for joining us for our next session of Baird's Global Healthcare Conference. I'm Joel Beatty, one of Baird's biotech analysts, and I'm really pleased to have this session with BioMarin Pharmaceutical, and with us today we have CFO, Brian Mueller. Brian, thank you so much for joining us today.
Brian R. Mueller
BioMarin Pharmaceutical Inc. - CFO & Executive VP
Yes, thank you, Joel. Thank you for having us, and thanks. Thanks everyone for joining.
Questions & Answers
Joel Lawrence Beatty
Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
Cool. So, obviously, today you had your R&D Day, which I was really excited about, knowing that you'll be in town around the time of our conference. And then the heartbreaking aspect of it is I haven't even been able to catch-up on it myself yet. But I'd love to hear more about it from you
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot